COVID-19: Still a place for the convalescent plasma? Focus on the immunocompromised patients

被引:1
|
作者
Richier, Q. [1 ,2 ]
Hueso, T. [3 ]
Tiberghien, P. [4 ,5 ]
Lacombe, K. [1 ,2 ,6 ]
机构
[1] Sorbonne Univ, Paris, France
[2] Hop St Antoine, Serv Malad Infect, AP HP, F-75012 Paris, France
[3] Sorbonne Univ Paris Nord, Serv Hematol Clin, Hop Avicenne, AP HP, Bobigny, France
[4] Etab Francais Sang, La Plaine St Denis, France
[5] Univ Franche Comte, Etab Francais Sang, UMR 1098 Right Inserm, Besancon, France
[6] Inserm, Inst Pierre Louis Epidemiol & Sante Publ, UMRS1136, Paris, France
来源
REVUE DE MEDECINE INTERNE | 2023年 / 44卷 / 09期
关键词
COVID-19; SARS-CoV-2; Convalescent plasma; Immunocompromised; THERAPY;
D O I
10.1016/j.revmed.2023.08.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:467 / 471
页数:5
相关论文
共 50 条
  • [1] Treatment of immunocompromised COVID-19 patients with convalescent plasma
    Fung, Monica
    Nambiar, Ashok
    Pandey, Suchi
    Aldrich, J. Matthew
    Teraoka, Justin
    Freise, Christopher
    Roberts, John
    Chandran, Sindhu
    Hays, Steven R.
    Bainbridge, Emma
    DeVoe, Catherine
    Roque Gardner, Annelys
    Yokoe, Deborah
    Henrich, Timothy J.
    Babik, Jennifer M.
    Chin-Hong, Peter
    TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (02)
  • [2] COVID-19 convalescent plasma retains value for immunocompromised patients
    Focosi, Daniele
    Franchini, Massimo
    LEUKEMIA, 2023, 37 (08) : 1762 - 1763
  • [3] COVID-19 convalescent plasma retains value for immunocompromised patients
    Daniele Focosi
    Massimo Franchini
    Leukemia, 2023, 37 : 1762 - 1763
  • [4] COVID 19 convalescent plasma: Is there still a place for CCP?
    Moog, Rainer
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (02)
  • [5] Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients
    Franchini, Massimo
    Casadevall, Arturo
    Senefeld, Jonathon W.
    Joyner, Michael J.
    Sullivan, David J.
    Focosi, Daniele
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2024, 50 (04): : 648 - 653
  • [6] Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19
    Rodionov, Roman N.
    Biener, Anne
    Spieth, Peter
    Achleitner, Martin
    Hoelig, Kristina
    Aringer, Martin
    Mingrone, Geltrude
    Corman, Victor M.
    Drosten, Christian
    Bornstein, Stefan R.
    Tonn, Torsten
    Kolditz, Martin
    LANCET MICROBE, 2021, 2 (04): : E138 - E138
  • [7] WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
    Franchini, Massimo
    Casadevall, Arturo
    Joyner, Michael J. J.
    Focosi, Daniele
    LIFE-BASEL, 2023, 13 (01):
  • [8] Convalescent plasma for patients with COVID-19
    Zeng, Furong
    Chen, Xiang
    Deng, Guangtong
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (23) : 12528 - 12528
  • [9] Convalescent plasma transfusion for immunocompromised viremic patients with COVID-19: A retrospective multicenter study
    Destremau, Marjolaine
    Chaussade, Helene
    Hemar, Victor
    Beguet, Mathilde
    Bellecave, Pantxika
    Blanchard, Elodie
    Barret, Amaury
    Laboure, Gaelle
    Vasco-Moynet, Claire
    Lacassin, Flore
    Morisse, Eloise
    Aguilar, Claire
    Lafarge, Xavier
    Lafon, Marie-Edith
    Bonnet, Fabrice
    Issa, Nahema
    Camou, Fabrice
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (04)
  • [10] COVID-19 convalescent plasma in immunocompromised COVID-19 patients: more certainty and clarity are added to a complex evidence base
    Yoon, Hyunah
    Pirofski, Liise-anne
    EBIOMEDICINE, 2025, 114